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ABSTRACT 
The objective of present work is to achieve improvement in solubility and dissolution using Epalrestat with β-cyclodextrin ternary 
complex with addition of L-arginine. Kneading method with and without incorporation of L-arginine was used to obtain the solid 
systems (binary and ternary complex) of Epalrestat with β-cyclodextrin and characterized for DSC, PXRD, SEM. Phase solubility, 
saturation solubility, dissolution and stability studies were carried out. The effect of L-arginine was investigated on complexation 
efficiency of β-cyclodextrin towards Epalrestat in an aqueous media through phase solubility according to Higuchi and Connors. 
Phase solubility studies showed AL (linear) type of solubility curve in presence of L-arginine, the complexation efficiency and 
association constant of β-cyclodextrin towards Epalrestat were promoted by L-arginine signifying its use as a ternary component. 
Dissolution rate of Epalrestat and solubility were significantly improved by complexation with β-cyclodextrin as compared to 
Epalrestat alone. Ternary complex incorporated with L-arginine proved better than binary complex. Hence, L-arginine could be 
exploited as a ternary component to improve the solubility of Epalrestat via β-cyclodextrin complexation. 
Keywords: Epalrestat, solubility enhancement, inclusion complexes, β-cyclodextrin, L-arginine. 
 
Article Info: Received 26 Sep 2018;     Review Completed 24 Oct 2018;     Accepted  25 Oct 2018;     Available online 15 Nov 2018 
Cite this article as:  
Jagtap S, Magdum C, Enhanced dissolution and solubility of Epalrestat with β-Cyclodextrin ternary complex using 
Arginine, Journal of Drug Delivery and Therapeutics. 2018; 8(6):62-67                                                                                       
DOI: http://dx.doi.org/10.22270/jddt.v8i6.2014          
*Address for Correspondence:  
Jagtap Sneha, Annasaheb Dange College of B Pharmacy, Ashta, Sangli - 416301 Maharashtra, India. 
 
 
1. INTRODUCTION 
Epalrestat (EPL), 2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-
enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-
yl]acetic acid is a water-insoluble drug (14μM) that inhibits 
aldose reductase.1 The most common long-term 
complication in patients with diabetes mellitus is diabetic 
neuropathy.2 And EPL is used in its treatment.3 in 
hyperglycemic conditions; EPL reduces intracellular 
sorbitol accumulation, which can be efficacious in treating 
diabetic neuropathy. Main complications in patients with 
diabetes mellitus are neuropathy, retinopathy and 
nephropathy. 4,5 Cyclodextrins (CDs) have mainly been 
used as complexing agents to increase aqueous solubility, 
bioavailability and stability of drugs by the pharmaceutical 
industries. CDs are cyclic α-(1,4)-linked oligosaccharides of 
α-D-glucopyranose containing a relatively hydrophobic 
central cavity and a hydrophilic external surface.6,7 In 
present research paper, we proposed to improve solubility 
and the dissolution behavior of EPL by β- cyclodextrin (CD) 
and its ternary complex with L-arginine (ARG). CDs have 
the ability to form inclusion complex with many drug 
molecules entrapping the guest molecule partially or 
completely within the cyclodextrin cavity thus resulting in 
an increase in the solubility of the drug. First, phase 
solubility studies were performed, which conﬁrmed 
complexation of β-CD and EPL in aqueous solution. 
Numerous investigations reported that, incorporation of 
small quantity of hydrophilic excipients such as organic 
acids, amino acids, basic compounds, and polymers to an 
aqueous complexation medium usually give rise to an 
enhancement in the complexation efficiency of 
cyclodextrins and ultimately reduce their amounts in 
pharmaceutical formulations.8 The purpose of the current 
study was to ameliorate the aqueous solubility, dissolution 
rate and thus bioavailability of EPL and this is achieved by  
ternary complexation of β-CD with EPL employing amino 
acids.9-13 The solubility of EPL in absence of β-CD, Intrinsic 
solubility (S0) was determined. Complexation with ARG 
also promoted apparent stability constant (Ks) of ternary 
as compared to binary complex. The basic amino acid, ARG 
was proved to be a better option as an auxiliary substance 
to increase complexation efficiency (CE) of CDs in ternary 
complex.  
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Figure 1: Chemical Structure of EPL 
Thus considering the upper hand advantage of adding 
amino acid as a ternary component during complexation of 
drug with β-CD, the present investigation was carried out 
to contribute the promotion of the solubility of poorly 
water-soluble drug, EPL via β-CD complexation using ARG 
as an auxiliary substance, which to our knowledge has not 
been reported yet. 
2. MATERIALS AND METHODS 
2.1. Materials  
Epalrestat was a generous gift from Zydus Cadila 
Ahmadabad (India). β-CD and ARG were purchased from 
unique chemicals. All other reagents and solvents used 
were of analytical grade. 
2.2. Analysis of Epalrestat using a UV-visible 
spectrophotometer 
First, 100 µg/ml stock solution of Epalrestat was prepared 
in methanol and further dilutions were made in distilled 
water ranging from 03-18 µg/ml. The calibration curve was 
obtained by recording the absorbance on a UV 
spectrophotometer (Shimadzu UV spectrophotometer 
1800) at 390 nm. 14 Linearity in the calibration curve was 
observed with regression R2 = 0.994. 
2.3. Phase solubility studies   
The solubility behavior of EPL was examined in distilled 
water at room temperature (25 ± 2 °C) according to the 
method described by (Higuchi and Connors 1965) [15]. 
Excess amount of EPL(50mg) was added to 20 mL of 
aqueous solutions containing various concentrations of β-
CD (1mM –10mM) with or without addition of ARG (0.25% 
w/v). The suspensions were mechanically shaken 
subsequently on rotary shaker for 72 h at 125 rpm until 
equilibrium was achieved. The samples were filtered 
through Whatman filter paper 41, diluted if necessary and 
analyzed spectrophotometrically (Shimadzu UV 
spectrophotometer 1800) at 390 nm. The association 
constant (Ks) of complex and CE of β-CD were calculated 
according to the equations (1) and (2) respectively 1, 16.  
Ks = Slope /S0 (1-Slope)                                                       (1)  
S0 is the solubility of EPL in absence of β-CD and slope is 
obtained from the phase solubility diagram obtained by 
plotting moles of drug on y-axis and moles of β-CD on x-
axis. It gives idea about the linear dependence of drug 
concentration to β-CD concentration, with slope ratio 
below one usually assumes 1:1 ratio of the complex and 
refers to AL (linear) type of the phase solubility curve.  
CE = S0.K 1:1 = Slope / (1-Slope)                                        (2)  
2.4. Preparation of Binary and kneaded ternary 
complexes 
Binary complex (BC) – For binary complex EPL and β-CD 
were weighed accurately, mixed thoroughly by triturating 
in a mortar and sieved through a 120 sieve. Binary complex 
were stored in a desiccator until further evaluation. 
Kneaded complex (KC) – The kneaded complex of EPL, β-
CD and amino acid was prepared by wetting the physical 
mixture in a mortar with a minimum volume of 
ethanol/water mixture (15/85, V/V) and kneading 
thoroughly with a pestle to obtain a paste, which was then 
dried under vacuum at room temperature, sieved through a 
120 sieve and stored in a desiccator until further 
evaluation. 
2.5. Fourier transform infrared spectroscopy (FTIR) 
Analysis 
FTIR spectroscopy was performed on a Fourier Transform 
Infrared Spectrometer (Alpha T Bruker). Spectra were 
collected in the 4000–400 cm−1 range. 
2.6. Differential scanning calorimetry (DSC) Analysis  
Thermograms of EPL, β-CD, ternary complex were 
recorded on a Mettler Toledo, Staresw 920. Each sample 
(2-4mg) was heated in crimped aluminum pans at a 
scanning rate of 100C/min in an atmosphere of nitrogen 
using the range of 100-2400C. The temperature calibrations 
were performed periodically using indium as a standard.  
2.7. Powder X-ray diffractometry (PXRD) Analysis  
To obtain the changes in the crystallanity of the ternary 
complex prepared, the PXRD study was carried out by 
using X ray diffractometer (Miniflex 600 X-Ray 
Diffractometer Rigaku Corporation Japan). For this the 
samples of pure drug, β-CD, and prepared ternary complex  
were irradiated with monochromatised CuKα radiation and 
analyzed between from 5° to 60° (2θ).  
2.8. Scanning electron microscopy (SEM) Analysis 
The surface morphological features of EPL, binary, ternary 
complex were investigated using a scanning electron 
microscope (VEG A3 TESCAN) operated at an acceleration 
voltage of 20 kV and obtained microphotographs were 
examined at X500 and X2000 magnifications. 
2.9.    Saturation solubility studies  
Saturation solubility studies of EPL, binary and ternary 
complexes were conducted in triplicate. An excess amount 
of EPL and complexes were added to 20 mL of distilled 
water in vials sealed with stoppers and shaken in rotary 
flask shaker at room temperature (25 ± 0.5°C) for 24 h. A 
portion of solution was withdrawn, filtered through 
Whatman filter paper 41 and analyzed 
spectrophotometrically (Shimadzu UV spectrophotometer 
1800) at 390 nm. 16 
2.10.   Dissolution studies  
In vitro dissolution studies for EPL and its binary and 
ternary complexes were carried out using USP Type-II 
dissolution test apparatus (EDT 08LX Electrolab). Sample 
equal to 100 mg of EPL was used in each test. The   
dissolution   tests   were   performed using 900 ml of 
phosphate buffer pH 6.8 at 37 ± 0.50C with RPM maintained 
at 100. The release of EPL from each sample was 
determined by withdrawing 5 ml samples at preset time 
intervals, and were filtered, appropriately diluted and 
analyzed spectrophotometrically (Shimadzu UV 
spectrophotometer 1800) at 390 nm. 5 ml of fresh medium 
was transferred to maintain sink conditions.  
2.11. Stability Study 
Stability study binary and ternary complexes of EPL was 
carried out with the help of (Remi SC-19 Plus) by storing 
1gm of each selected complex in an ambered coloured 
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screw capped glass bottles at accelerated and controlled 
temperatures 400C and relative humidities (75%) for a 
period of 3 months. The complexes were evaluated for 
physical appearance, drug content and in-vitro dissolution 
at the end of three months. 8 
3. RESULTS AND DISCUSSION 
3.1.   Phase solubility studies   
The complexing nature of EPL along with β-CD in water 
was studied by the phase solubility as per standards set by 
Higuchi and Connors 1965. Fig.2 shows the phase solubility 
diagrams of EPL with β-CD and that of ARG. A typical BS-
type solubility profile as stated by Higuchi and Connors 
classification system was shown by the EPL and β-CD, 
binary complex. BS-type response stands for development 
of inclusion complexes of limited solubility within the 
range of β-CD concentrations examined.  The solubility of 
EPL with β-CD was higher than pure EPL. The phase 
solubility profile of EPL in aqueous β-CD solution in 
presence of 0.25% ARG displayed AL type of solubility 
curve with linear increase in solubility of EPL with 
increasing the concentration of β-CD. And slopes curves of 
phase solubility profile were lesser than 1 characterizing 
the formation of a 1:1 stoichiometry water soluble 
complex. 15-18 The values of Ks and CE of complex increased 
with the incorporation of ARG to the binary complex 
showing more effectiveness of ternary system over binary. 
The values of Ks for binary complex and ternary complex 
were found to be 505.18 and 876.47 respectively. 
Complexation efficiency of binary complex was found to be 
0.24 and for ternary complex it was 0.48 which is almost 
double of binary complex. Advancement in phase solubility 
parameters of EPL by complexation with β-CD in presence 
of ARG can be attributed to its electrostatic/hydrogen 
bonding interaction and salt formation with β-CD and EPL. 
19, 20 
 
Figure 2: Phase solubility diagrams of EPL: β-CD (Binary 
complex) and EPL: β-CD: ARG (ternary complex) in water. 
3.2.   FTIR measurements 
The molecular interaction between EPL and β-CD was 
revealed by FTIR. Fig.3 shows the FTIR spectra of binary 
and ternary complex. For EPL, principle absorption peaks 
were found near to 1742, 1673, and 1555 cm−1 from 
carboxyl, amide, and thiocarbonyl stretching vibrations, 
respectively. All these principle characteristic peaks were 
retained and did not shift both in binary and ternary 
complex. As the results, it is concluded that EPL is 
dispersed uniformly in the β-CD. 
 
 
Figure 3: FTIR spectra of A) EPL B) Pure β-CD C) Binary complex D)EPL:β-CD:ARG ternary system 
 
3.3.   DSC measurements 
DSC analyses were performed to evaluate the thermal 
behavior of EPL, β-CD and ternary complex, respectively 
(Fig. 4) and interaction between EPL and β-CD in complex 
formation. When guest molecule incorporated into 
cyclodextrin central cavity, their melting point shift to 
different temperature or it may disappear. One sharp 
endothermic peak was observed near around 2150C 
contributed to the fusion of crystalline EPL in the ternary 
thermograms broad endothermic peak was observed near 
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around 1400C, which can be attributed to dehydration 
during the heating process of the β-CD. In the ternary 
complex, the endothermic peak obtained from EPL 
decreased or almost disappeared. It may be due to low 
interaction between the components in the ternary 
complex. These results suggested that EPL and β-CD were 
molecularly dispersed in the amorphous form in ternary 
complex.
 
 
Figure 4: DSC thermograms of A) EPL B) Binary complex C) EPL:β-CD:ARG ternary system 
 
3.4.    PXRD measurements 
PXRD patterns of EPL, binary and ternary complex (molar 
ratio 1:1) are represented in Fig. 5. The pattern of the 
ternary complex could be interpreted as superposition of 
EPL and β-CD representing absences of crystalline traces of 
EPL indicating entrapment of EPL in β-CD. In ternary 
systems, the overlapping of β-CD and ARG crystalline peaks 
was observed. The PXRD showed a halo pattern and no 
diﬀraction peak occurred when EPL was kneaded with β-
CD at a 1:1 molar ratio. Crystalline EPL turned amorphous 
by kneading with β-CD. It was revealed that the crystalline 
structure of EPL was distorted and EPL molecules were 
converted into amorphous state. 
 
 
Figure 5: PXRD patterns of A) EPL B) Binary complex C) EPL:β-CD:ARG ternary complex 
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3.5.   SEM analysis 
The surface morphological features of EPL and ternary 
complexes are shown in Fig. 6. Separate entities of 
amorphous broken particles of Pure EPL were appeared 
(Fig. 6A). Binary complex particles exhibited altered shape 
and agglomerate type morphology (Fig. 6B) due to 
crystalline nature of β-CD. Change in morphology of 
ternary complexes was observed due to the crystalline 
nature of β-CD and ARG (Fig. 6C) showing agglomerated 
crystalline images. The alerted morphology of kneaded 
complexes particles indicates existence of a single phase 
within the complex attaining maximum complexation. 21 
 
 
Figure 6: SEM images of A) Pure EPL B) Binary complex C) EPL:β-CD:ARG ternary complex 
 
3.6.    Saturation solubility studies  
Remarkable enhancement in the solubility of binary and 
ternary complex as compared to pure EPL was observed in 
the saturation solubility studies. Pure EPL exhibited a 
solubility of 47± 0.04 µg/mL in distilled water. The binary 
and ternary complexes have shown solubility of 98.7± 0.30 
and 163.09± 0.72µg/mL, respectively. There was 210% 
increment in the solubility of binary complex and 347% 
increment in the solubility of ternary complex was 
observed which was almost double than binary complex. 
Formation of stable complex of EPL and β-CD, altered 
surface morphological features of the complexes due to 
kneading and inclusion into the hydrophobic β-CD cavity 
resulted in the enhancement in solubility of complex. ARG 
imparts significant role as a ternary component resulting 
in improved performance than binary complex22.   
3.7.   In vitro dissolution studies  
EPL and its corresponding binary and ternary complexes 
were evaluated for dissolution properties and compared to 
the pure EPL. The in-vitro dissolution results were 
assessed on the basis of cumulative percentage drug 
release, dissolution efficiency and correlation coefficient 
(r).  
The dissolution curves of EPL and ternary complexes are 
shown in Fig.7. An enhancement in dissolution profile was 
observed for solid complexes as compared to pure EPL. 
The binary complex has shown almost 60% drug release in 
60min. And ternary complex demonstrated grater 
dissolution profile as compared to binary complex with 
78.18% drug release within 60 min in dissolution media. 
Phase solubility parameters such as Ks and CE were greatly 
promoted and resulted in the greater fruitfulness of 
ternary complex. Higher release rate was due to positive 
effect of addition of basic amino acid ARG.12,20,23 Hence, we 
can arrive at a judgment that ternary complex of EPL with 
β-CD and ARG could be reliable approach for improved 
dissolution properties.          
 
Figure 7: Dissolution profile of pure drug, binary and 
ternary kneaded complex 
 
3.8.   Stability Study 
There was no significant change in the physical 
appearance, drug content and percent drug dissolution in 
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the EPL complexes. A stability results clearly indicate that 
the complexes were sufficiently stable under accelerated 
and controlled conditions. 
4. CONCLUSION  
From the present investigation it is concluded that the 
formulated complexes revealed the key   performance of β-
CD and ARG to ameliorate the solubility and dissolution 
rate of EPL and also suggests a significant increase in the 
complexation efficiency between EPL and β-CD by addition 
of small amounts of amino acid ARG by kneading. 
Formation of inclusion complexes, greatly enhance the 
solubility of EPL, which can thus increase its bioavailability 
and improving pharmaceutical potential of the drug. 
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